Company Registration No. SC476268 (Scotland)
The Antibody Company Limited
Unaudited accounts
for the year ended 30 April 2024
The Antibody Company Limited
Unaudited accounts
Contents
The Antibody Company Limited
Company Information
for the year ended 30 April 2024
Company Number
SC476268 (Scotland)
Registered Office
10 Church Avenue
Newmains
Lanarkshire
ML2 9BH
Accountants
Assenti & Noble Ltd
18 Mosshead Road
Bearsden
Glasgow
G61 3HN
The Antibody Company Limited
Statement of financial position
as at 30 April 2024
Intangible assets
7,592
9,111
Tangible assets
28,622
34,000
Cash at bank and in hand
77,874
38,598
Creditors: amounts falling due within one year
(147,723)
(45,931)
Net current assets
8,217
10,586
Total assets less current liabilities
44,431
53,697
Creditors: amounts falling due after more than one year
(37,876)
(44,839)
Called up share capital
1,000
1,000
Profit and loss account
5,555
7,858
Shareholders' funds
6,555
8,858
For the year ending 30 April 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies. The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The director acknowledges his responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with the provisions of FRS 102 Section 1A - Small Entities. The profit and loss account has not been delivered to the Registrar of Companies.
The financial statements were approved by the Board and authorised for issue on 14 January 2025 and were signed on its behalf by
E Wagner
Director
Company Registration No. SC476268
The Antibody Company Limited
Notes to the Accounts
for the year ended 30 April 2024
The Antibody Company Limited is a private company, limited by shares, registered in Scotland, registration number SC476268. The registered office is 10 Church Avenue, Newmains, Lanarkshire, ML2 9BH.
2
Compliance with accounting standards
The accounts have been prepared in accordance with the provisions of FRS 102 Section 1A Small Entities. There were no material departures from that standard.
The principal accounting policies adopted in the preparation of the financial statements are set out below and have remained unchanged from the previous year, and also have been consistently applied within the same accounts.
The accounts have been prepared under the historical cost convention.
The accounts are presented in £ sterling.
Intangible fixed assets comprising purchased licences are capitalised and written off on a straight line basis over a 10 year period. Provision is made for any impairment in value.
Tangible fixed assets policy
Depreciation has been provided at the following rates in order to write off the assets over their estimated useful lives:
Plant & machinery
between 2 & 5 years straight line
Computer equipment
4 years straight line
4
Intangible fixed assets
Other
The Antibody Company Limited
Notes to the Accounts
for the year ended 30 April 2024
5
Tangible fixed assets
Plant & machinery
Computer equipment
Total
Cost or valuation
At cost
At cost
At 1 May 2023
154,879
21,355
176,234
Additions
6,684
3,665
10,349
At 30 April 2024
161,563
25,020
186,583
At 1 May 2023
121,506
20,728
142,234
Charge for the year
14,278
1,449
15,727
At 30 April 2024
135,784
22,177
157,961
At 30 April 2024
25,779
2,843
28,622
At 30 April 2023
33,373
627
34,000
Amounts falling due within one year
Trade debtors
25,549
12,552
Accrued income and prepayments
2,480
330
7
Creditors: amounts falling due within one year
2024
2023
Bank loans and overdrafts
5,833
10,000
Obligations under finance leases and hire purchase contracts
8,809
9,742
Trade creditors
10,344
5,653
Taxes and social security
800
1,060
Other creditors
48,844
15,133
Deferred income
18,000
1,875
8
Creditors: amounts falling due after more than one year
2024
2023
Obligations under finance leases and hire purchase contracts
16,149
23,169
The Antibody Company Limited
Notes to the Accounts
for the year ended 30 April 2024
Allotted, called up and fully paid:
1,000 Ordinary shares of £1 each
1,000
1,000
10
Average number of employees
During the year the average number of employees was 5 (2023: 6).